Evaluation of recombinant dengue viral envelope B domain protein antigens for the detection of dengue complex-specific antibodies

被引:31
|
作者
Simmons, M
Porter, KR
Escamilla, J
Graham, R
Watts, DM
Eckels, KH
Hayes, CG
机构
[1] USN, Med Res Inst, Dept Infect Dis, Bethesda, MD 20889 USA
[2] USN, Ctr Environm Hlth, Norfolk, VA 23513 USA
[3] Walter Reed Army Inst Res, Dept Biol Res, Washington, DC 20307 USA
[4] USN, Med Res Unit 2, Jakarta, Indonesia
[5] USN, Med Res Inst Detachment, Lima, Peru
来源
关键词
D O I
10.4269/ajtmh.1998.58.144
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
To increase the specificity of dengue (DEN) diagnosis based on antibody detection, we have evaluated recombinant proteins as antigens that incorporate most of the B domain of the DEN virus envelope protein fused to the trpE protein of Escherichia coli (trpE-DEN). A pooled antigen consisting of trpE-DEN proteins representing all four serotypes of DEN virus was used in an indirect ELISA for the detection of IgG or IgM antibody. This assay was compared with a standard IgG indirect ELISA and an IgM-capture ELISA using DEN virus-infected cell culture pooled antigens. The results indicated that the trpE-DEN antigens and the cell culture antigens were equally sensitive for detecting IgM and IgG antibodies in convalescent sera from Peru and Indonesia representing virus isolation-confirmed primary and secondary DEN infections, respectively. Fourteen day postinfection IgG antibody-positive sera obtained from individuals infected with DEN-1 virus who had been vaccinated with other flaviviruses were more strongly reactive with the cell culture antigen than with the recombinant antigen, but by day 21 postinfection, a strong antibody response to the trpE-DEN antigens was present. These results suggested that the early antibody response was directed predominantly towards shared flavivirus group antigens that were not detected with the trpE-DEN antigens. Comparison of the trpE-DEN-1 recombinant antigen with a DEN-1 virus-infected cell lysate antigen for the detection of IgG antibody in sera from a cohort of 55 individuals from Peru who seroconverted over a one-year period indicated greater specificity for the recombinant antigens. Also, sera from individuals with no known DEN infections that had been sequentially vaccinated with yellow fever and Japanese encephalitis reacted with the DEN virus cell culture antigen in the IgG ELISA, but did not react with the trpE-DEN pooled antigens. Similarly, YF IgM antibody positive samples that showed cross-reactivity with the DEN virus cell. culture antigens, did not react with the trpE-DEN pooled antigens. These results indicated that the trpE-DEN pooled antigen provided a more specific diagnosis of dengue infections than DEN virus-infected cell culture antigen and avoided the biohazards associated with handling live virus during the preparation of diagnostic reagents. The trpE-DEN pooled antigen should permit a better approach to distinguish between past DEN and other flavivirus infections in epidemiologic surveys, and also increase the specificity of serologic diagnosis of acute DEN infections.
引用
收藏
页码:144 / 151
页数:8
相关论文
共 50 条
  • [21] Chimeric flavivirus enables evaluation of antibodies against dengue virus envelope protein in vitro and in vivo
    Takeshi Kurosu
    Keiko Hanabara
    Azusa Asai
    Sabar Pambudi
    Supranee Phanthanawiboon
    Magot Diata Omokoko
    Ken-ichiro Ono
    Masayuki Saijo
    Pongrama Ramasoota
    Kazuyoshi Ikuta
    Scientific Reports, 10
  • [22] A recombinant fusion protein containing the domain III of the dengue-2 envelope protein is immunogenic and protective in nonhuman primates
    Hermida, L
    Bernardo, U
    Martín, J
    Alvarez, M
    Prado, I
    López, C
    Sierra, BDL
    Martínez, R
    Rodríguez, R
    Zulueta, A
    Pérez, AB
    Lazo, L
    Rosario, D
    Guillén, G
    Guzmán, MG
    VACCINE, 2006, 24 (16) : 3165 - 3171
  • [23] A DNA vaccine targeting the dengue virus envelope protein domain III elicits specific antibodies and CD4+ T cells
    Zaneti, A. B.
    Yamamoto, M. M.
    Sulczewski, F. B.
    Almeida, B. S.
    Souza, H. F. S.
    Ferreira, N. S.
    Maeda, D. L. N. F.
    Sales, N. S.
    Rosa, D. S.
    Ferreira, L. C. S.
    Boscardin, S. B.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1688 - 1688
  • [24] Cloning and expression of a recombinant envelope domain III antigen from a Dengue 1 serotype viral isolate in Escherichia coli
    Ngo Thu Huong
    La Huy Hoang
    Truong Quoc Phong
    2023 1ST INTERNATIONAL CONFERENCE ON HEALTH SCIENCE AND TECHNOLOGY, ICHST 2023, 2023,
  • [25] Specific detection of dengue and Zika virus antibodies using envelope proteins with mutations in the conserved fusion loop
    Rockstroh, Alexandra
    Moges, Beyene
    Barzon, Luisa
    Sinigaglia, Alessandro
    Palu, Giorgio
    Kumbukgolla, Widuranga
    Schmidt-Chanasit, Jonas
    Sarno, Manoel
    Brites, Carlos
    Moreira-Soto, Andres
    Drexler, Jan Felix
    Ferreira, Orlando C.
    Ulbert, Sebastian
    EMERGING MICROBES & INFECTIONS, 2017, 6 : e99
  • [26] Recombinant lipidated dengue-3 envelope protein domain III stimulates broad immune responses in mice
    Chiang, Chen-Yi
    Liu, Shih-Jen
    Hsieh, Chun-Hsiang
    Chen, Mei-Yu
    Tsai, Jy-Ping
    Liu, Hsueh-Hung
    Chen, I. -Hua
    Chong, Pele
    Leng, Chih-Hsiang
    Chen, Hsin-Wei
    VACCINE, 2016, 34 (08) : 1054 - 1061
  • [27] Immunogenicity of a novel tetravalent vaccine formulation with four recombinant lipidated dengue envelope protein domain IIIs in mice
    Chen-Yi Chiang
    Chien-Hsiung Pan
    Mei-Yu Chen
    Chun-Hsiang Hsieh
    Jy-Ping Tsai
    Hsueh-Hung Liu
    Shih-Jen Liu
    Pele Chong
    Chih-Hsiang Leng
    Hsin-Wei Chen
    Scientific Reports, 6
  • [28] Immunogenicity of a recombinant envelope domain III protein of dengue virus type-4 with various adjuvants in mice
    Babu, J. Pradeep
    Pattnaik, Priyabrata
    Gupta, Nimesh
    Shrivastava, Ambuj
    Khan, Mohsin
    Rao, P. V. Lakshmana
    VACCINE, 2008, 26 (36) : 4655 - 4663
  • [29] Immunogenicity of a novel tetravalent vaccine formulation with four recombinant lipidated dengue envelope protein domain IIIs in mice
    Chiang, Chen-Yi
    Pan, Chien-Hsiung
    Chen, Mei-Yu
    Hsieh, Chun-Hsiang
    Tsai, Jy-Ping
    Liu, Hsueh-Hung
    Liu, Shih-Jen
    Chong, Pele
    Leng, Chih-Hsiang
    Chen, Hsin-Wei
    SCIENTIFIC REPORTS, 2016, 6
  • [30] Induction of protective antibodies against dengue virus by tetravalent DNA immunization of mice with domain III of the envelope protein
    Mota, J
    Acosta, M
    Argotte, R
    Figueroa, R
    Méndez, A
    Ramos, C
    VACCINE, 2005, 23 (26) : 3469 - 3476